(Q28242307)

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

The structural requirements for complement activation by IgG: does it hinge on the hinge?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

New monoclonal antibodies specific for human sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Immunoscintigraphy of bone sarcomas--results in 5 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Human and mouse monoclonal antibodies by repertoire cloning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Conformations of immunoglobulin hypervariable regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Rapid expression of an anti-human C5 chimeric Fab utilizing a vector that replicates in COS and 293 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Antibody framework residues affecting the conformation of the hypervariable loops

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

High-level expression of chimeric antibodies using adapted cDNA variable region cassettes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

SV40-transformed simian cells support the replication of early SV40 mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

SEQHUNT. A program to screen aligned nucleotide and amino acid sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Construction and expression of chimeric antibodies by a simple replacement of heavy and light chain V genes into a single cassette vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Optimization of primers for cloning libraries of mouse immunoglobulin genes using the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Rapid and efficient site-specific mutagenesis without phenotypic selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Continuous cultures of fused cells secreting antibody of predefined specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Phage antibodies: filamentous phage displaying antibody variable domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Transfectomas provide novel chimeric antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

A hapten-specific chimaeric IgE antibody with human physiological effector function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

The intron requirement for immunoglobulin gene expression is dependent upon the promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: location of lysine residues and implications for radiolabeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Cloning immunoglobulin variable domains for expression by the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

The genetic engineering of monoclonal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Aglycosylated chimaeric human IgG3 can trigger the human phagocyte respiratory burst

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

A humanized antibody that binds to the interleukin 2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Reshaping human antibodies for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Expression of an antibody Fv fragment in myeloma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

A COS-cell-based system for rapid production and quantification of scFv::IgC kappa antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

C1q binding to chimeric monoclonal IgG3 antibodies consisting of mouse variable regions and human constant regions with shortened hinge containing 15 to 47 amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: construction of a heavy chain variable region-specific cDNA library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

A new vector for the high level expression of chimeric antibodies in myeloma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Signal sequences. The limits of variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3

Making antibodies by phage display technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900034-3